Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CardioDynamics (CDIC) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (78)	7/12/2000 7:34:27 AM
From: Marc Phelan	Respond to of 201

Tuck, "We could move it to the $10 and under section if you really cared." Gee... I had hopes that it will be over $10 by the end of the month! <grin> {No I really don't care where they put it as long as the share price continues up.} Yesterdays news with GE was probably more than a "minor marketing coup". The alliance with GE Marquette Medical Systems puts BioZ® Impedance Cardiography technology into virtually all the hospitals in the U.S. Long term it seems great news! The best, Marc

To: tuck who wrote (78)	7/20/2000 7:45:08 AM
From: Marc Phelan	Respond to of 201

More Good News! Tuck, See: biz.yahoo.com Significant International Study Highlighting CardioDynamics --CDIC-- BioZ.com Presented at 7th World Congress Heart Failure Meeting. The best Marc

To: tuck who wrote (78)	7/26/2000 7:24:49 AM
From: Marc Phelan	Read Replies (1) \| Respond to of 201

Turk we got the money! Company Broadens Institutional Investor Ownership SAN DIEGO--(BW HealthWire)--July 26, 2000--CardioDynamics International Corporation (Nasdaq\NM:CDIC), manufacturer of BioZ® noninvasive digital cardiac function monitoring systems, announced that on July 25, 2000, it completed an $18.5 million private placement of common stock primarily to institutional investors, providing additional capital to execute the Company's aggressive business plan. The Company intends to use the proceeds to advance commercialization of its BioZ Systems and secure its position as the leader in noninvasive hemodynamic monitoring. See: biz.yahoo.com Regarding the passing of Allen E. Paulson, co-chairman, the company said, "The Company has learned that no shares will need to be sold to pay estate taxes and that there will be no significant sales of shares by Mr. Paulson's estate. Additionally, there will be no disruption of operations or any other material effect on the Company from his passing." Good news and better news?